(19)
(11) EP 2 590 651 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.08.2018 Bulletin 2018/32

(45) Mention of the grant of the patent:
27.06.2018 Bulletin 2018/26

(21) Application number: 11740859.1

(22) Date of filing: 06.07.2011
(51) International Patent Classification (IPC): 
A61K 31/496(2006.01)
A61K 31/663(2006.01)
A61K 31/7056(2006.01)
A61P 33/00(2006.01)
A61K 31/664(2006.01)
A61K 31/662(2006.01)
A61P 33/06(2006.01)
(86) International application number:
PCT/EP2011/061447
(87) International publication number:
WO 2012/004324 (12.01.2012 Gazette 2012/02)

(54)

NEW DRUG COMBINATIONS FOR THE TREATMENT OF MALARIA

NEUE KOMBINATIONSPRÄPARATE ZUR BEHANDLUNG VON MALARIA

NOUVELLES COMBINAISONS POUR LE TRAITEMENT DU PALUDISME


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 06.07.2010 EP 10168641

(43) Date of publication of application:
15.05.2013 Bulletin 2013/20

(73) Proprietor: BioAgency AG
20354 Hamburg (DE)

(72) Inventors:
  • HUTCHINSON, David
    Kent TN16 2DR (GB)
  • GUTTERIDGE, Winston
    Kent TN13 1QD (GB)

(74) Representative: Simandi, Claus 
Badehausallee 55
27476 Cuxhaven
27476 Cuxhaven (DE)


(56) References cited: : 
EP-B1- 1 305 031
JP-A- 2001 081 034
WO-A1-2010/004573
   
  • YOKOTA Y ET AL: "IN VITRO SYNERGISM OF FR-31564, A NEW PHOSPHONIC ACID ANTIBIOTIC", JOURNAL OF ANTIBIOTICS, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION, TOKYO, JP, vol. 34, no. 7, 1 July 1981 (1981-07-01), pages 876-883, XP000867644, ISSN: 0021-8820
  • SNYDER ET AL: "In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models", EXPERIMENTAL PARASITOLOGY, NEW YORK, NY, US, vol. 115, no. 3, 2 December 2006 (2006-12-02), pages 296-300, XP005724230, ISSN: 0014-4894, DOI: DOI:10.1016/J.EXPPARA.2006.09.016
  • BERENBAUM M C: "A method for testing for synergy with any number of agents", JOURNAL OF INFECTIOUS DISEASES, UNIVERSITY OF CHICAGO PRESS, CHICAGO, IL, vol. 137, no. 2, 1 January 1978 (1978-01-01), pages 122-130, XP008082150, ISSN: 0022-1899 cited in the application
  • ARAV-BOGER RAVIT ET AL: "Molecular mechanisms of resistance in antimalarial chemotherapy: the unmet challenge.", ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 2005 LNKD- PUBMED:15822189, vol. 45, 2005, pages 565-585, XP002610469, ISSN: 0362-1642
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).